These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 18571499)

  • 1. TiO2 nanoparticles promote beta-amyloid fibrillation in vitro.
    Wu WH; Sun X; Yu YP; Hu J; Zhao L; Liu Q; Zhao YF; Li YM
    Biochem Biophys Res Commun; 2008 Aug; 373(2):315-8. PubMed ID: 18571499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of amyloid beta protein fibrillation by polymeric nanoparticles.
    Cabaleiro-Lago C; Quinlan-Pluck F; Lynch I; Lindman S; Minogue AM; Thulin E; Walsh DM; Dawson KA; Linse S
    J Am Chem Soc; 2008 Nov; 130(46):15437-43. PubMed ID: 18954050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative metabolites accelerate Alzheimer's amyloidogenesis by a two-step mechanism, eliminating the requirement for nucleation.
    Bieschke J; Zhang Q; Powers ET; Lerner RA; Kelly JW
    Biochemistry; 2005 Apr; 44(13):4977-83. PubMed ID: 15794636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-amyloid fibril formation is promoted by step edges of highly oriented pyrolytic graphite.
    Losic D; Martin LL; Aguilar MI; Small DH
    Biopolymers; 2006; 84(5):519-26. PubMed ID: 16752395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of fluorinated and hydrogenated nanoparticles on the structure and fibrillogenesis of amyloid beta-peptide.
    Rocha S; Thünemann AF; Pereira Mdo C; Coelho M; Möhwald H; Brezesinski G
    Biophys Chem; 2008 Sep; 137(1):35-42. PubMed ID: 18625543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new evidence for DNA nicking property of amyloid beta-peptide (1-42): relevance to Alzheimer's disease.
    Suram A; Hegde ML; Rao KS
    Arch Biochem Biophys; 2007 Jul; 463(2):245-52. PubMed ID: 17502108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid of Alzheimer patients promotes beta-amyloid fibril formation in vitro.
    Ono K; Noguchi M; Matsumoto Y; Yanase D; Iwasa K; Naiki H; Yamada M
    Neurobiol Dis; 2005 Nov; 20(2):233-40. PubMed ID: 16242632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docosahexaenoic acid disrupts in vitro amyloid beta(1-40) fibrillation and concomitantly inhibits amyloid levels in cerebral cortex of Alzheimer's disease model rats.
    Hashimoto M; Shahdat HM; Yamashita S; Katakura M; Tanabe Y; Fujiwara H; Gamoh S; Miyazawa T; Arai H; Shimada T; Shido O
    J Neurochem; 2008 Dec; 107(6):1634-46. PubMed ID: 19014387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PEGylated phospholipid nanomicelles interact with beta-amyloid((1-42)) and mitigate its beta-sheet formation, aggregation and neurotoxicity in vitro.
    Pai AS; Rubinstein I; Onyüksel H
    Peptides; 2006 Nov; 27(11):2858-66. PubMed ID: 16762454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomers.
    Robert R; Dolezal O; Waddington L; Hattarki MK; Cappai R; Masters CL; Hudson PJ; Wark KL
    Protein Eng Des Sel; 2009 Mar; 22(3):199-208. PubMed ID: 18927231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescence anisotropy: a method for early detection of Alzheimer beta-peptide (Abeta) aggregation.
    Allsop D; Swanson L; Moore S; Davies Y; York A; El-Agnaf OM; Soutar I
    Biochem Biophys Res Commun; 2001 Jul; 285(1):58-63. PubMed ID: 11437372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation of toxic fibrils of Alzheimer's amyloid beta-protein-(1-40) by monosialoganglioside GM1, a neuronal membrane component.
    Okada T; Wakabayashi M; Ikeda K; Matsuzaki K
    J Mol Biol; 2007 Aug; 371(2):481-9. PubMed ID: 17582434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and biological activity of beta-sheet breaker peptide conjugates.
    Rocha S; Cardoso I; Börner H; Pereira MC; Saraiva MJ; Coelho M
    Biochem Biophys Res Commun; 2009 Mar; 380(2):397-401. PubMed ID: 19250644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visualization and classification of amyloid beta supramolecular assemblies.
    Yagi H; Ban T; Morigaki K; Naiki H; Goto Y
    Biochemistry; 2007 Dec; 46(51):15009-17. PubMed ID: 18044976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Collagenous Alzheimer amyloid plaque component assembles amyloid fibrils into protease resistant aggregates.
    Söderberg L; Dahlqvist C; Kakuyama H; Thyberg J; Ito A; Winblad B; Näslund J; Tjernberg LO
    FEBS J; 2005 May; 272(9):2231-6. PubMed ID: 15853808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.
    Takahashi T; Mihara H
    Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid-like formation by self-assembly of peptidolipids in two dimensions.
    Li C; Orbulescu J; Sui G; Leblanc RM
    Langmuir; 2004 Sep; 20(20):8641-5. PubMed ID: 15379486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of copper(II) inhibiting Alzheimer's amyloid beta-peptide from aggregation: a molecular dynamics investigation.
    Jiao Y; Yang P
    J Phys Chem B; 2007 Jul; 111(26):7646-55. PubMed ID: 17564430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formation of highly toxic soluble amyloid beta oligomers by the molecular chaperone prefoldin.
    Sakono M; Zako T; Ueda H; Yohda M; Maeda M
    FEBS J; 2008 Dec; 275(23):5982-93. PubMed ID: 19021772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood-borne factors inhibit Alzheimer's beta-amyloid fibril formation in vitro.
    Ono K; Noguchi-Shinohara M; Samuraki M; Matsumoto Y; Yanase D; Iwasa K; Naiki H; Yamada M
    Exp Neurol; 2006 Nov; 202(1):125-32. PubMed ID: 16806179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.